Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.37)
# 3,485
Out of 5,182 analysts
177
Total ratings
41.33%
Success rate
-3.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $6 → $8 | $4.34 | +84.33% | 18 | Dec 2, 2025 | |
| IRTC iRhythm Holdings | Maintains: Overweight | $195 → $205 | $122.35 | +67.55% | 18 | Dec 2, 2025 | |
| MDT Medtronic | Maintains: Overweight | $107 → $117 | $83.32 | +40.42% | 11 | Nov 19, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $91.26 | +4.10% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $482.22 | +34.79% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $9.22 | +30.15% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $110.93 | -14.36% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $75.80 | +12.14% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $37.76 | -60.28% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $189.56 | +80.95% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.27 | +1,002.36% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $18.16 | +164.32% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $84.15 | +21.21% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $62.07 | -6.56% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.82 | +26.42% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $61.57 | +112.77% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $91.13 | +45.95% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $327.51 | -32.83% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $136.56 | +176.80% | 2 | Feb 25, 2022 |
Sight Sciences
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $6 → $8
Current: $4.34
Upside: +84.33%
iRhythm Holdings
Dec 2, 2025
Maintains: Overweight
Price Target: $195 → $205
Current: $122.35
Upside: +67.55%
Medtronic
Nov 19, 2025
Maintains: Overweight
Price Target: $107 → $117
Current: $83.32
Upside: +40.42%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $91.26
Upside: +4.10%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $482.22
Upside: +34.79%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $9.22
Upside: +30.15%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $110.93
Upside: -14.36%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $75.80
Upside: +12.14%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $37.76
Upside: -60.28%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $189.56
Upside: +80.95%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.27
Upside: +1,002.36%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $18.16
Upside: +164.32%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $84.15
Upside: +21.21%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $62.07
Upside: -6.56%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.82
Upside: +26.42%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $61.57
Upside: +112.77%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $91.13
Upside: +45.95%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $327.51
Upside: -32.83%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $136.56
Upside: +176.80%